Stoke Therapeutics
STOK
STOK
181 hedge funds and large institutions have $2.13B invested in Stoke Therapeutics in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 54 increasing their positions, 58 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 58
6.26% less ownership
Funds ownership: 123.53% → 117.27% (-6.3%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
181
Holding in Top 10
4
Calls
$20.3M
Puts
$2.51M
Top Buyers
| 1 | +$54.8M | |
| 2 | +$33.6M | |
| 3 | +$32.2M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$18.3M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.4M |
Top Sellers
| 1 | -$39M | |
| 2 | -$38M | |
| 3 | -$27.5M | |
| 4 |
BlackRock
New York
|
-$23.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$18.1M |
